237 related articles for article (PubMed ID: 15049964)
1. First trimester levels of inhibins and activin A in normal and failing pregnancies.
Wallace EM; Marjono B; Tyzack K; Tong S
Clin Endocrinol (Oxf); 2004 Apr; 60(4):484-90. PubMed ID: 15049964
[TBL] [Abstract][Full Text] [Related]
2. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
Davidson EJ; Riley SC; Roberts SA; Shearing CH; Groome NP; Martin CW
BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935
[TBL] [Abstract][Full Text] [Related]
3. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
Spencer K; Cowans NJ; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493
[TBL] [Abstract][Full Text] [Related]
4. Inhibin A and activin A may be used to predict pregnancy outcome in women with recurrent miscarriage.
Prakash A; Laird S; Tuckerman E; Li TC; Ledger WL
Fertil Steril; 2005 Jun; 83(6):1758-63. PubMed ID: 15950648
[TBL] [Abstract][Full Text] [Related]
5. Maternal serum activin A and inhibin A in trisomy 18 pregnancies at 10-14 weeks.
Spencer K; Liao AW; Ong CY; Flack NJ; Nicolaides KH
Prenat Diagn; 2001 Jul; 21(7):571-4. PubMed ID: 11494294
[TBL] [Abstract][Full Text] [Related]
6. Uterine vein and maternal urinary levels of activin A and inhibin A in pre-eclampsia patients.
Muttukrishna S; Hyett J; Paine M; Moodley J; Groome N; Rodeck C
Clin Endocrinol (Oxf); 2006 Apr; 64(4):469-73. PubMed ID: 16584522
[TBL] [Abstract][Full Text] [Related]
7. First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction.
Ong CY; Liao AW; Munim S; Spencer K; Nicolaides KH
J Matern Fetal Neonatal Med; 2004 Mar; 15(3):176-80. PubMed ID: 15280143
[TBL] [Abstract][Full Text] [Related]
8. Comparison of serum markers in first-trimester down syndrome screening.
Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
[TBL] [Abstract][Full Text] [Related]
9. Total activin A in maternal blood as a marker of preterm delivery in low-risk asymptomatic patients.
Farina A; Lambert-Messerlian GM; Canick JA; Banzola I; Carletti A; Concu M; Tempesta A; Gabrielli S; Morano D; Rizzo N
Prenat Diagn; 2006 Mar; 26(3):277-81. PubMed ID: 16506265
[TBL] [Abstract][Full Text] [Related]
10. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia.
Yu J; Shixia CZ; Wu Y; Duan T
Ultrasound Obstet Gynecol; 2011 May; 37(5):528-33. PubMed ID: 20737451
[TBL] [Abstract][Full Text] [Related]
11. Correlation between second trimester maternal serum inhibin-A and human chorionic gonadotrophin for the prediction of pre-eclampsia.
Aquilina J; Maplethorpe R; Ellis P; Harrington K
Placenta; 2000; 21(5-6):487-92. PubMed ID: 10940198
[TBL] [Abstract][Full Text] [Related]
12. Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.
Spencer K; Crossley JA; Aitken DA; Nicolaides KH
Prenat Diagn; 2005 May; 25(5):358-61. PubMed ID: 15906423
[TBL] [Abstract][Full Text] [Related]
13. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy.
Ay E; Kavak ZN; Elter K; Gokaslan H; Pekin T
Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):283-8. PubMed ID: 16029293
[TBL] [Abstract][Full Text] [Related]
14. Placental and maternal serum inhibin-A and activin-A levels in Down's syndrome pregnancies.
Dalgliesh GL; Aitken DA; Lyall F; Howatson AG; Connor JM
Placenta; 2001; 22(2-3):227-34. PubMed ID: 11170828
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum inhibin A levels are a marker of a viable trophoblast in incomplete and complete miscarriage.
Luisi S; Florio P; D'Antona D; Severi FM; Sanseverino F; Danero S; Petraglia F
Eur J Endocrinol; 2003 Feb; 148(2):233-6. PubMed ID: 12590643
[TBL] [Abstract][Full Text] [Related]
16. Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the villous tissue of miscarriage patients.
Muttukrishna S; Bearfield C; Johns J; Jauniaux E
Mol Hum Reprod; 2004 Nov; 10(11):793-8. PubMed ID: 15361555
[TBL] [Abstract][Full Text] [Related]
17. Inhibin-B and pro-alphaC-containing inhibins in amniotic fluid from chromosomally normal and Down syndrome pregnancies.
Wallace EM; Crossley JA; Riley SC; Balfour C; Groome NP; Aitken DA
Prenat Diagn; 1998 Mar; 18(3):213-7. PubMed ID: 9556037
[TBL] [Abstract][Full Text] [Related]
18. Preliminary prospective study of the endocrinology of conception cycles and early pregnancy in women with antiphospholipid syndrome treated with low molecular weight heparin.
Prakash A; Laird S; Li TC; Ledger WL
Fertil Steril; 2006 Jan; 85(1):165-70. PubMed ID: 16412749
[TBL] [Abstract][Full Text] [Related]
19. Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy.
Lambert-Messerlian GM; Canick JA; Palomaki GE; Schneyer AL
J Med Screen; 1996; 3(2):58-62. PubMed ID: 8849760
[TBL] [Abstract][Full Text] [Related]
20. Adhesion molecules, activin and inhibin--candidates for the biochemical prediction of hypertensive diseases in pregnancy?
Hanisch CG; Pfeiffer KA; Schlebusch H; Schmolling J
Arch Gynecol Obstet; 2004 Sep; 270(2):110-5. PubMed ID: 12898146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]